The potential of brain natriuretic peptide as a biomarker for New York Heart Association class during the outpatient treatment of heart failure

Journal of Cardiac Failure

Volumn 8, Issue 3, 2002, Pages 149-154

  Lee, Shang Chiun ^a   Stevens, Tracy L ^a   Sandberg, Sharon M ^a   Heublein, Denise M ^a   Nelson, Susan M ^a   Jougasaki, Michihisa ^a   Redfield, Margaret M ^a   Burnett Jr , John C ^a  

^a MAYO CLINIC   (United States)

Author keywords

Heart failure; Natriuretic peptides; NYHA class

Indexed keywords

ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKER; BRAIN NATRIURETIC PEPTIDE; C TERMINAL ATRIAL NATRIURETIC PEPTIDE; N TERMINAL ATRIAL NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG; ATRIAL NATRIURETIC FACTOR (4 23)NH2, DE GLN(18) DE SER(19) DE GLY(20,22) DE LEU(21); ATRIAL NATRIURETIC FACTOR (4-23)NH2, DE-GLN(18)-DE-SER(19)-DE-GLY(20,22)-DE-LEU(21)-; N TERMINAL PROATRIAL NATRIURETIC PEPTIDE; N-TERMINAL PROATRIAL NATRIURETIC PEPTIDE; PEPTIDE FRAGMENT; PROTEIN PRECURSOR;

ADULT; AGED; ARTICLE; CONGESTIVE HEART FAILURE; DIAGNOSTIC VALUE; ECHOCARDIOGRAPHY; FEMALE; FUNCTIONAL ASSESSMENT; HEART LEFT VENTRICLE EJECTION FRACTION; HORMONE BLOOD LEVEL; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; OUTPATIENT CARE; PATIENT MONITORING; PRIORITY JOURNAL; RADIOIMMUNOASSAY; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY; AMBULATORY CARE; BLOOD; CLASSIFICATION; CLINICAL TRIAL; HEART LEFT VENTRICLE FUNCTION; MIDDLE AGED; SINGLE BLIND PROCEDURE; TREATMENT OUTCOME;

ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ATRIAL NATRIURETIC FACTOR; BIOLOGICAL MARKERS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; PROTEIN PRECURSORS; RADIOIMMUNOASSAY; SINGLE-BLIND METHOD; TREATMENT OUTCOME; VENTRICULAR DYSFUNCTION, LEFT;

EID: 0036023205     PISSN: 10719164     EISSN: None     Source Type: Journal    
DOI: 10.1054/jcaf.2002.125368     Document Type: Article

References (12)

1. The natriuretic peptides in heart failure: Diagnostic and therapeutic potentials
2. Atrial natriuretic peptide elevation in congestive heart failure in the human
3. Brain natriuretic peptide as a novel cardiac hormone in humans. Evidence for an exquisite dual natriuretic peptide system, atrial natriuretic peptide and brain natriuretic peptide
4. Differential atrial and ventricular expression of myocardial BNP during evolution of heart failure
5. Superiority of brain natriuretic peptide as a hormonal marker of ventricular systolic and diastolic dysfunction and ventricular hypertrophy
6. Titration of vasodilator therapy in chronic heart failure according to plasma brain natriuretic peptide concentration: Randomized comparison of the hemodynamic and neuroendocrine effects of tailored versus empirical therapy
7. Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations
8. Symptomatic and asymptomatic left-ventricular systolic dysfunction in an urban population
9. Clinical criteria and biochemical marker for the detection of systolic dysfunction
10. Increased plasma levels of brain natriuretic peptide in patients with acute myocardial infarction
11. Detection of left ventricular dysfunction after acute myocardial infarction: Comparison of clinical, echocardiographic, and neurohormonal methods
12. Utility of B-type natriuretic peptide in the diagnosis of congestive heart failure in an urgent-care setting